Hemodilution Indicators
Hemodilution is primarily indicated by a decrease in hemoglobin and hematocrit levels that occurs disproportionately to red blood cell mass, reflecting an increase in plasma volume rather than true anemia.
Laboratory Findings
The most reliable laboratory indicators of hemodilution include:
- Decreased hemoglobin concentration: Falls of 0.8-1.1 g/dL below baseline 1
- Decreased hematocrit: Reductions of 2.3-3.6% from baseline values 1
- Normal or preserved red blood cell indices: No evidence of increased red cell turnover or changes in other cellular blood components 1
- Stable or normal serum ferritin: Distinguishes hemodilution from true iron deficiency anemia
Important Caveat for Pregnancy
In pregnant women, hemoglobin or hematocrit measurement alone is imprecise for determining true iron deficiency versus physiologic hemodilution, as normal pregnancy causes physiologic anemia through plasma volume expansion 2. Serum ferritin has limited utility in late pregnancy as it decreases despite adequate iron stores and increases during inflammation 2.
Clinical Context
Hemodilution occurs in several clinical scenarios:
Iatrogenic Hemodilution
- Acute normovolemic hemodilution (ANH): Deliberate removal of blood with simultaneous cell-free fluid replacement using synthetic colloids 3
- Cardiopulmonary bypass: Hemodilution accounts for approximately 35% ± 7% decrease in coagulation and fibrinolytic protein concentrations during routine bypass, making it the primary cause of protein dilution (far exceeding blood loss at 6% ± 5% or consumption at <1%) 4
Medication-Induced
- Thiazolidinediones (TZDs): Cause plasma volume expansion of approximately 1.8 mL/kg, resulting in hemoglobin decreases of 0.8-1.1 g/dL and hematocrit falls of 2.3-3.6% 1
- These changes typically occur within the first weeks of therapy and plateau thereafter 1
Physiologic States
- Heart failure with volume overload: Studies using 131I-tagged albumin demonstrate plasma volume expansion in >50% of patients without clinically recognized volume overload 5
- Pregnancy: Physiologic plasma volume expansion occurs normally 2
Key Distinguishing Features
What hemodilution is NOT:
- No evidence of increased red blood cell turnover or destruction 1
- No effect on erythropoiesis 1
- Cellular components of blood remain unchanged 1
- Represents dilution of existing blood components rather than true deficiency states
Clinical Monitoring
When hemodilution is suspected or induced:
- Serial hemoglobin/hematocrit measurements show progressive decline
- Changes in body weight may indicate fluid retention (though unreliable long-term in heart failure due to muscle wasting or non-fluid weight gain) 5
- In therapeutic hemodilution, target hematocrit of 20-25% (7.0-8.0 g/dL hemoglobin) is generally safe in healthy subjects 3
Critical threshold: Oxygen delivery increases as hematocrit is reduced up to approximately 28-30%, but below this level oxygen delivery begins to decline 6.